TMXgroup

January 21, 2010

BioExx Specialty Proteins Ltd. (the "Company") - An application has been granted for the original listing in the Industrial category of 178,825,495 common shares of which 157,091,117 common shares are issued and outstanding and 21,734,378 common shares are reserved for issuance.

The common shares of the Company will be listed and posted for trading at the opening on Friday, January 22, 2010.

The Company is subject to the reporting requirements of Section 501 of the TSX Company Manual.

Stock Symbol: "BXI"
CUSIP: 090634 10 6
Trading Currency: CDN

Market Maker: Macquarie Capital Markets Canada Ltd.

Other Markets: On May 9, 2007, Lifesciences Capital Corp. ("LCC"), a capital pool company incorporated under the Business Corporations Act (Ontario), completed its qualifying transaction with Bio-Extraction Ltd. ("Bio-Exx"), a private company incorporated in Prince Edward Island by Letters Patent dated January 10, 2003, pursuant to which LCC acquired all of the outstanding common shares of Bio-Exx, and changed its name to "Bio-Extraction Inc." On January 4, 2010, Bio-Exx changed its name to its current name, BioExx Special Proteins Ltd. ("BioExx")". The common shares of BioExx will be delisted from TSX Venture Exchange on January 22, 2010.

Additional information on the common shares of the Company may be found in the Annual Information Form ("AIF") for the year ended December 31, 2008 which is available at www.SEDAR.com. Capitalized terms not otherwise defined are as defined in the AIF.

Head Office Address: 219 (North) Dufferin Street
Suite 100B
Toronto, Ontario M6K 3J1

Email Address: cschnarr@bioexx.com

Website: www.bioexx.com

Telephone Number: (416) 588-4442

Fax Number: (416) 588-1999

Investor Relations: Scott Koyich
President, Brisco Capital Partners
(403) 262-9888
scott@briscocapitalcom

Chief Financial Officer and Corporate Secretary: Chris Schnarr

Incorporation: On May 9, 2007, LLC, a capital pool company completed its qualifying transaction with Bio-Exx and changed its name to "Bio-Extraction Inc." On January 4, 2010, Bio-Exx changed its name to its current name, BioExx Special Proteins Ltd.

Fiscal Year End: Dec 31

Nature of Business: The Company has developed a proprietary technology for extracting oil, meal and specialty proteins from canola seed.

Transfer Agent & Registrar: Equity Transfer & Trust Company ("Equity Transfer") at its principal office in Toronto.

Dividends: The Company does not anticipate declaring and paying any dividends in the foreseeable future.

Recent Financings The Company completed a private placement on October 15, 2009 for gross proceeds of $15 million sold by a syndicate of agents led by Canaccord Capital Corporation and including Wellington West Capital Markets Inc., Loewen Ondaatje McCutcheon Limited, and Fraser Mackenzie Limited. The offering consisted of 12,000,000 common shares at $1.25 per share.